***This is for informational purposes only, Insight Women’s Center does not provide the abortion pill.
The FDA approved regimen for Mifiprex (RU-486) is a two-visit process using two different drugs
- Mifepristone is given orally during the first office visit. Mifepristone blocks progesterone from sustaining the pregnancy, thereby ending the life of the baby.
- Misoprostol tablets are given orally 48 hours later. The misoprostol will cause contractions to expel the baby’s remains. This does not take place at a medical office and may occur within a few hours or up to two weeks after taking misoprostol.
- A physical exam is given by the healthcare provider about 7-14 days later to ensure the abortion is complete and that there are no immediate complications.
Risks and Side Effects
- Not advised for women who have anemia, bleeding disorders, liver or kidney disease, seizure disorder, and acute inflammatory bowel disease, use an intrauterine device (IUD), or are unable to return for the follow-up visit.
- Cramping, nausea, vomiting, diarrhea, heavy bleeding, infection and in rare cases, death.
- In a small percentage of pregnancies, the procedure may be unsuccessful in terminating the pregnancy. This risk increases with the length of your pregnancy.